Alumis IncALMS
Price$7.39

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 30 Jun 2026
Market Price $7.39Price as of 30 Sep 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 12.8%/yr (balance of the path).11.2% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 612.5%Yr 712.2%Yr 811.9%Yr 911.6%Yr 1011.2%
12.8% → 11.2%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1110.4%Yr 129.6%Yr 138.8%Yr 147.9%Yr 157.1%Yr 166.3%Yr 175.5%Yr 184.6%Yr 193.8%Yr 203.0%
11.2% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 5.4%
Volatility vs market (adjusted beta)-0.19

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAlumis IncALMSHealth Care
Valuation
P/E—
P/S136.8×
P/B2.5×
EV / Revenue133.2×
EV / EBITDA—
Profitability
Gross margin100.0%
Operating margin-1,886.9%
Net margin-5,933.5%
FCF margin-4,755.3%
Returns
ROE-97.1%
ROA-78.3%
ROIC—
Growth
Revenue growth (YoY)—
5-yr fwd EPS growth11.2%
Financial strength
Debt / Equity0.08×
Current ratio6.74×
Altman Z-Score1.2
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.